A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines

Tomasz Korzeniowski; Jerzy Strużyna; Anna M. Chrapusta; Andrzej Krajewski; Marek Kucharzewski; Krzysztof Piorun; Jakub Nowakowski; Agnieszka Surowiecka; Magdalena Kozicka; Kamil Torres

doi:10.12659/MSM.935632

22 January 2022 : Clinical Research

A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines

Tomasz Korzeniowski^12ABCDEFG*, Jerzy Strużyna^13ACDEFG, Anna M. Chrapusta^4ABCDE, Andrzej Krajewski^5ABDE, Marek Kucharzewski^6ABDEF, Krzysztof Piorun

^5ABCE, Jakub Nowakowski^7BCDF, Agnieszka Surowiecka^1ACDE, Magdalena Kozicka^12ABDF, Kamil Torres^12BDEG

DOI: 10.12659/MSM.935632

Med Sci Monit 2022; 28:e935632

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 2 Consensus statements and agreement on pain management for enzymatic debridement.

No	Statement	Agreement	Likert scale	Consensus
9	Adequate pain management is an inherent requirement of enzymatic debridement-based treatment	100%	5/5 strongly agree	Yes

Back to the Article

A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines

Your Privacy